ROS1 at the Crossroads of Clinical Oncology, Molecular Diagnostics, and Drug Development

JCO Oncol Pract. 2021 Jan;17(1):15-16. doi: 10.1200/OP.20.00969.

Authors

Igor Odintsov^{1

2}, Romel Somwar^{1

2}, Marc Ladanyi^{1

2}, Alexander Drilon^{3

4}

Affiliations

¹ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.
² Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.
³ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
⁴ Department of Medicine, Weill Cornell Medical College, New York, NY.

PMID: 33434449
DOI: 10.1200/OP.20.00969

No abstract available

Publication types

Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung*
Drug Development
Humans
Lung Neoplasms*
Medical Oncology
Pathology, Molecular
Protein-Tyrosine Kinases
Proto-Oncogene Proteins

Substances

Proto-Oncogene Proteins
Protein-Tyrosine Kinases
ROS1 protein, human